Stocks · Health care · Biological Products, (No Diagnostic Substances)

Replimune Group, Inc.

REPL Clue Score21

United States Fiscal year ends March CIK 0001737953 Results filed 28 Oct 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.34M

$274.25K on a plan · $441.46K straight out of an exercise

Sold at will

$1.63M

13 of 18 sales

Net

−$2.34M

−$1.63M against sales at will